HomeProductsBioactive CompoundsMAPK/ERK Pathwayp38 MAPKDilmapimod
Chemical structure of CAS 444606-18-2

Dilmapimod

In Stock•Starting at $185 for 25 mg•Purity ≥ 99%
CAS No.444606-18-2
MDL No.MFCD16659063
MFC23H19F3N4O3
MW456.40
InChI KeyORVNHOYNEHYKJG-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
25 mg99%$185In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.444606-18-2
Product NameDilmapimod

Biological Targets

MAPK14

Associated Conditions

acute lung injury·coronary artery disease·neuropathic pain·chronic obstructive pulmonary disease·rheumatoid arthritis
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Design and synthesis of inhaled p38 inhibitors for the treatment of chronic obstructive pulmonary disease.

Journal of medicinal chemistry • Vol. 54, Issue 22 • 2011
PMID: 21888439DOI: 10.1021/jm200677b

p38 pathway kinases as anti-inflammatory drug targets.

Journal of dental research • Vol. 86, Issue 9 • 2007
PMID: 17720847DOI: 10.1177/154405910708600902

Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology • Vol. 18, Issue 13 • 2004
PMID: 15289440DOI: 10.1096/fj.04-1642fje

Documentation